Concepedia

Author

Kimberly Hayes

The University of Texas MD Anderson Cancer Center

Also Known As

K Hayes, K J Hayes, K.J. Hayes, Kimberly Hayes, Kimberly J Hayes, Kimberly J. Hayes

44

Publications

2.6K

Citations

22

H-Index

51

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterInstitute of Neuroimmunology of the Slovak Academy of Sciences
KH

About

Kimberly Hayes is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

18

1.3K

2

Cell Biology

7

7

736

3

Health Sciences

6

6

407

4

Engineering

1

1

11

5

Biomedical Engineering

1

1

11

Kimberly Hayes

×

32

Publications

2.5K

Citations

22

H-Index

YearCitations

A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

Lei L. Chen, Jonathan C. Trent, Elsie F. Wu,

Cancer Research

2004

341

A Genetically Defined Model for Human Ovarian Cancer

Jinsong Liu, Gong Yang, Jennifer A. Thompson-Lanza,

Cancer Research

2004

273

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Nicholas J. Donato, Ji Yuan Wu, Jonathan Stapley,

Cancer Research

2004

214

Topotecan and Cytarabine Is an Active Combination Regimen in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Miloslav Beran, Elihu H. Estey, Susan O’Brien,

Journal of Clinical Oncology

1999

138

Prognostic value of cytogenetics in multiple myeloma

Chu‐Myong Seong, Kay Delasalle, Kimberly Hayes,

British Journal of Haematology

1998

137

Chromosomal abnormalities in Philadelphia chromosome‐negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia in chronic phase

Jorge Medina, Hagop Kantarjian, Moshe Talpaz,

Cancer

2003

132

Cytogenetic Findings in Lymphoplasmacytic Lymphoma /Waldenström Macroglobulinemia

Adnan Mansoor, L. Jeffrey Medeiros, Donna M. Weber,

American Journal of Clinical Pathology

2001

123

Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.

Hagop M. Kantarjian, Moshe Talpaz, Susan O’Brien,

PubMed

2002

123

Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia

Alfonso Quintás‐Cardama, Hagop M. Kantarjian, Moshe Talpaz,

Blood

2004

112

Mature B-Cell Leukemias With More Than 55% Prolymphocytes

Ellen Schlette, Carlos E. Bueso‐Ramos, Francis J. Giles,

American Journal of Clinical Pathology

2001

105

Page 1